Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ніколай Борісовіч СорокінfiledCriticalНіколай Борісовіч Сорокін
Priority to UAU201401313UpriorityCriticalpatent/UA91281U/en
Publication of UA91281UpublicationCriticalpatent/UA91281U/en
A method for manufacturing the drug formulation containing one or more dosage units of the Mifepriston-based pharmaceutical composition possessing the pronounced antigestagenic activity comprises weighing and sieving the powders of the active ingredient and excipients, mixing the said powders followed by the compression process resulting in tabletted dosage units of the drug formulation. The microcrystalline cellulose, sodium carboxymethyl starch, and calcium stearate or magnesium stearate are used as the excipients. The direct compression process with dedusting is used for manufacturing the tablets.
UAU201401313U2014-02-102014-02-10Method for manufacturing drug formulation possessing pronounced antigestagenic activity
UA91281U
(en)
Pharmaceutical composition including multi-unit spheroidal tablet containing esomeprazole and spheroidal pharmaceutically acceptable salt thereof, and method of preparing the pharmaceutical composition
Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation